Bancreek Global Select ETF
BCGSNYSEARCABancreekEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $40.76M
- Expense ratio
- 0.80%
- Dividend yield
- 0.50%
- Holdings
- 59
- 52-week range
- $23.50$28.83
- Volume (live)
- -
- Avg. volume (3M)
- 147
BCGS ETF: Bancreek Global Select ETF - Price, Holdings & Analysis
Bancreek Global Select ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $25.54 - $25.54 |
|---|---|
| 52-Week High | $28.83 |
| 52-Week Low | $23.50 |
| Open | $25.54 |
| Volume (last close) | 22 |
| Average Volume (3M) | 147 |
| 1 Day Change | +0.19% |
|---|---|
| 1 Month Change | −3.74% |
| 6 Month Change | −2.98% |
| YTD Change | +1.63% |
| Annual Dividend | $0.13 |
|---|---|
| Dividend Yield | 0.50% |
| Last Dividend Ex-Date | Sep 28, 2026 |
| Assets (AUM) | $40.76M |
|---|---|
| Expense Ratio | 0.80% |
| Total Holdings | 59 |
| Inception Date | Mar 8, 2026 |
| 50-Day MA | $27.40 |
|---|---|
| RSI | 33.45 |
| Stochastic %K | 0.00 |
| Stochastic %D | 3.72 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
BCGS at a Glance
Bancreek Global Select ETF (BCGS) is an equity ETF from Bancreek, launched in March 2026. It manages $40.76M in assets and charges a 0.80% expense ratio, about $80 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 59 positions. The largest are Codan Limited (ASX:CDA, 2.90%), Amneal Pharmaceuticals, Inc. (AMRX, 2.32%) and SK Square Co., Ltd. (KRX:402340, 2.28%). The top 10 holdings make up 22.7% of the fund. By sector it leans toward Industrials (28.6%), Technology (23.4%) and Consumer Discretionary (15.6%). Its largest country exposures are United States (58.0%), South Korea (8.1%) and Australia (6.6%).
It pays distributions yielding 0.50% at the Oct 16, 2026 close, $0.13 per share over the trailing 12 months.
Frequently Asked Questions About Bancreek Global Select ETF
What is the current price of BCGS?
The latest BCGS price is $25.54 (Oct 16, 2026 close). The 52-week range is $23.50–$28.83.
What is the expense ratio for BCGS?
BCGS's annual expense ratio is 0.80%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BCGS pay dividends?
Yes, BCGS pays a 0.50% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was September 28, 2026. View full dividend history in the Dividends section.
What are the top holdings of BCGS?
As of Oct 4, 2026, BCGS's largest holdings are Codan Limited (2.9%), Amneal Pharmaceuticals, Inc. (2.3%), SK Square Co., Ltd. (2.3%) (combined weight: 7.5%). The fund holds 59 total positions. View the complete portfolio breakdown in the Holdings section.
How does BCGS compare to similar ETFs?
Compare BCGS (0.80% expense ratio, $41M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.